ESR1 and triple-negative breast carcinoma: Triple-negative breast cancer (TNBC) is defined by the loss of expression of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor 2 (Her2neu) expressions and associated with biological aggressiveness and poor prognosis and two subtypes, basal and nonbasal, have been described [1].